Review Maternal depression: risk factors and treatment options during pregnancy

被引:2
作者
Conlon, Orla [1 ]
Lynch, Janine [2 ]
机构
[1] Erne Hosp, Cornagrade Rd, Enniskillen BT74 6AY, Fermanagh, North Ireland
[2] Belfast Hlth & Social Care Trust Trust, Belfast BT8 8BH, Antrim, North Ireland
关键词
antidepressive agents; fetal toxicity; selective serotonin re-uptake inhibitors; suicide; maternal death;
D O I
10.1576/toag.10.3.151.27417
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Key content: Psychiatric illness was identified as the leading cause of indirect death in the fifth and sixth CEMACH reports; the decrease in the rate of suicide in the seventh report may indicate that previous recommendations are having a beneficial effect. Half of the women identified in the earlier reports had a history of serious mental illness. Depression during pregnancy is complex and difficult to treat. Learning objectives: To learn about the background diagnosis and management. Ethical issues: How aggressive should any active approach be to reduce the risk of maternal death? Can the use of pharmacological agents which can cause fetal toxicity and neonatal withdrawal problems be justified?
引用
收藏
页码:151 / 155
页数:5
相关论文
共 32 条
[1]   Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies [J].
Addis, A ;
Koren, G .
PSYCHOLOGICAL MEDICINE, 2000, 30 (01) :89-94
[2]   Neonatal ACTH administration elicits long-term changes in forebrain monoamine innervation - Subsequent disruptions in hypothalamic-pituitary-adrenal and gonadal function [J].
Alves, SE ;
Akbari, HM ;
Anderson, GM ;
Azmitia, EC ;
McEwen, BC ;
Strand, FL .
NEUROPEPTIDES IN DEVELOPMENT AND AGING, 1997, 814 :226-251
[3]   Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn [J].
Chambers, CD ;
Hernandez-Diaz, S ;
Van Marter, LJ ;
Werler, MM ;
Louik, C ;
Jones, KL ;
Mitchell, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :579-587
[4]   Birth outcomes in pregnant women taking fluoxetine [J].
Chambers, CD ;
Johnson, KA ;
Dick, LM ;
Felix, RJ ;
Jones, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1010-1015
[5]   Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment [J].
Cohen, LS ;
Altshuler, LL ;
Harlow, BL ;
Nonacs, R ;
Newport, DJ ;
Viguera, AC ;
Suri, R ;
Burt, VK ;
Hendrick, V ;
Reminick, AM ;
Loughead, A ;
Vitonis, AF ;
Stowe, ZN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05) :499-507
[6]  
Confidential Enquiry into Maternal and Child Health, 2007, 7 REP CONF ENQ MAT D
[7]   Treating mood disorders during pregnancy - Safety considerations [J].
Eberhard-Gran, M ;
Eskild, A ;
Opjordsmoen, S .
DRUG SAFETY, 2005, 28 (08) :695-706
[9]   PSYCHOTROPIC-DRUGS IN PREGNANCY AND LACTATION [J].
GOLDBERG, HL .
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 1994, 24 (02) :129-147
[10]  
Isbister GK, 2001, ARCH DIS CHILD-FETAL, V85, pF147